WHO-ILEP Joint Meeting on Sentinel Surveillance of Drug Resistance, Cebu, Philippines, 5-6 February, 2014
The emergence of drug resistance is a cause for concern and a threat for any infectious disease intervention programme. For leprosy, a chronic disease with social stigma, drug resistance poses a serious impediment, especially at the stage where a dramatic decline in prevalence and new case detection has been achieved due to intensive and concerted chemotherapy interventions made by the national programmes and its global partners.
A leprosy free world is within our reach...
Leprosy is curable. Early diagnosis and treatment with multidrug therapy (MDT) are the key strategies of the leprosy programme. If left untreated, leprosy can cause progressive and permanent damage to the skin, nerves, limbs and eyes. MDT is available at all health facilities free of charge and close to 16 million leprosy patients have been cured with MDT over the past 20 years. 95% of the exposed population is NOT susceptible for leprosy ... A leprosy free world is within our reach ...
International Leprosy Summit: Overcoming the remaining challenges, Bangkok, Thailand, 24-26 July 2013
Advocacy for political commitment to leprosy control will have to continue, and with intensified efforts. This is to overcome complacency in countries; the complacency that is due to the understanding that leprosy has completely disappeared. Sustaining and maintaining that care and services for persons affected by leprosy are essential indeed. Even more important, the quality of these services has to be further improved, in the light of available know-how and technology. Deformity due to leprosy must be prevented and properly corrected and the affected persons rehabilitated socially and occupationally. ---Dr Samlee Plianbangchang, Regional Director, Regional Office for South-East Asia
WHO Goodwill Ambassador for Leprosy
Yohei Sasakawa is Chairman of The Nippon Foundation, a private, non-profit foundation established in 1962 for the purpose of carrying out philanthropic activities. He was appointed as WHO Goodwill Ambassador for Leprosy in May 2001. Sasakawa describes the elimination of leprosy as his life’s work. He spends almost one third of every year visiting endemic countries, meeting with political leaders to seek their political commitment to reduce the leprosy burden, liaising with health authorities and frontline health workers, talking to people affected by leprosy, supporting the reintegration of people affected by leprosy into mainstream society and making himself available to the media in order to raise public awareness of the issue.
In the spotlight
- WHO-ILEP Joint Meeting on Sentinel Surveillance of Drug Resistance, Cebu, Philippines, 5-6 February, 2014
- A leprosy free world is within our reach...
- International Leprosy Summit: Overcoming the remaining challenges, Bangkok, Thailand, 24-26 July 2013
- WHO Goodwill Ambassador for Leprosy
Facts and Features
Events and Meetings
Leprosy in WHO Regions
WHO - Global Leprosy Programme Regional Office for South-East Asia World Health House Indraprastha Estate Mahatma Gandhi Marg New Delhi 110 002, India Phone: +91-11-23370804, 23370809-11 email: email@example.com